| Development of therapeutic antibodies for the treatment of diseases RM Lu, YC Hwang, IJ Liu, CC Lee, HZ Tsai, HJ Li, HC Wu Journal of biomedical science 27, 1-30, 2020 | 1734 | 2020 |
| Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko, FY Ke, KH Liang, TY Hsieh, ... Journal of Biomedical Science 29 (1), 1, 2022 | 191 | 2022 |
| Transcription factor SOX‐5 enhances nasopharyngeal carcinoma progression by down‐regulating SPARC gene expression DY Huang, YT Lin, PS Jan, YC Hwang, ST Liang, Y Peng, CYF Huang, ... The Journal of pathology 214 (4), 445-455, 2008 | 79 | 2008 |
| NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression YC Hwang, TY Lu, DY Huang, YS Kuo, CF Kao, NH Yeh, HC Wu, CT Lin The American journal of pathology 175 (1), 342-354, 2009 | 40 | 2009 |
| Effect of Epstein–Barr virus infection on global gene expression in nasopharyngeal carcinoma YCG Lee, YC Hwang, KC Chen, YS Lin, DY Huang, TW Huang, CY Kao, ... Functional & integrative genomics 7, 79-93, 2007 | 32 | 2007 |
| Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association YC Hwang, CH Yang, CH Lin, HJ Ch'ang, VHS Chang, CY Winston Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1833 (12), 3035-3045, 2013 | 29 | 2013 |
| Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy CD Wu, HW Chou, YS Kuo, RM Lu, YC Hwang, HC Wu, CT Lin Oncology reports 27 (1), 94-100, 2012 | 21 | 2012 |
| Structure-guided antibody cocktail for prevention and treatment of COVID-19 SC Su, TJ Yang, PY Yu, KH Liang, WY Chen, CW Yang, HT Lin, MJ Wang, ... PLoS Pathogens 17 (10), e1009704, 2021 | 18 | 2021 |
| Embryonic early-cleavage rate is decreased with aging in GnRH agonist but not inantagonist protocols WJ Yang, YC Hwang, CS Lin, YM Hwu, RK Lee, SY Hsiao Journal of Assisted Reproduction and Genetics 32, 789-795, 2015 | 8 | 2015 |
| Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer FY Ke, WY Chen, MC Lin, YC Hwang, KT Kuo, HC Wu Cancer Science 111 (10), 3478-3492, 2020 | 6 | 2020 |
| NOLC1, a transcription factor, synergistically regulates MDM2 expression with TP53 to promote the progression of nasopharyngeal carcinoma YC Hwang, TY Lu, CT Lin, CF Kao, HC Wu, NH Yeh Cancer Research 68 (9_Supplement), LB-170-LB-170, 2008 | 1 | 2008 |
| Tumor immunity and immunosurveillance (PP-093) JP Abastado, J Eyles, A Puaux, J Wang, B Toh, C Prakash, M Hong, T Tan, ... International Immunology 22 (Suppl_1_Pt_3), iii144-iii172, 2010 | | 2010 |
| NOLC1, an enhancer for NPC progression, is essential for TP53 to regulate MDM2 expression YC Hwang, TY Lu, DY Huang, YS Kuo, CF Kao, NH Yeh, HC Wu, CT Lin American Journal of Pathology 175 (1), 342-354, 2009 | | 2009 |
| 鼻咽癌基因 NOLC1 調控腫瘤生長之機轉 YC Hwang 臺灣大學病理學研究所學位論文 2009, 1-132, 2009 | | 2009 |
| NOLC1 gene expression in Epstein-Barr virus infected nasopharyngeal carcinoma YC Hwang, DY Huang, NH Yeh, HC Wu, CT Lin Cancer Research 66 (8_Supplement), 791-792, 2006 | | 2006 |
Cheng-Fu KaoInstitute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan在 gate.sinica.edu.tw 的电子邮件经过验证
Cheng-Fu KaoInstitute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan在 gate.sinica.edu.tw 的电子邮件经过验证